A detailed history of Credit Agricole S A transactions in Repligen Corp stock. As of the latest transaction made, Credit Agricole S A holds 37 shares of RGEN stock, worth $5,275. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 7,337 99.5%
Holding current value
$5,275
Previous $924,000 99.46%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.79 - $167.35 $874,467 - $1.22 Million
-7,300 Reduced 99.5%
37 $5,000
Q2 2024

Aug 13, 2024

BUY
$120.0 - $182.95 $876,000 - $1.34 Million
7,300 Added 19729.73%
7,337 $924,000
Q1 2024

May 14, 2024

BUY
$170.78 - $208.42 $6,318 - $7,711
37 New
37 $6,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.